SCHEMBL673615

SCHEMBL673615

CC(C)(C)OC(=O)ON1CC(C#N)(c2ncccc2CCc2ccnc(Nc3ccc4c(c3)CC(=O)N4)n2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTK2 Q05397 16/20 0.43
PTK2B Q14289 10/20 0.43
TBK1 Q9UHD2 2/20 0.41
SRC P12931 2/20 0.39
GSK3A P49840 2/20 0.39
SYK P43405 1/20 0.39
MAPK14 Q16539 1/20 0.39
PLK4 O00444 1/20 0.38
AURKA O14965 1/20 0.38
PDPK1 O15530 1/20 0.38
DAPK3 O43293 1/20 0.38
JAK2 O60674 1/20 0.38
ROCK2 O75116 1/20 0.38
STK16 O75716 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
PAK4 O96013 1/20 0.38
CHEK2 O96017 1/20 0.38
NTRK1 P04629 1/20 0.38
PRKCG P05129 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10125376 0.91 PTK2 (0.44) PTK2PTK2BTBK1SRCGSK3A
SCHEMBL15023795 0.86 PTK2 (0.45) PTK2PTK2BTBK1SRCGSK3A
SCHEMBL670549 0.83 PTK2 (0.49) PTK2PTK2BTBK1SRCGSK3A
SCHEMBL670533 0.75 PTK2 (0.53) PTK2PTK2BTBK1SRCGSK3A
SCHEMBL670009 0.74 PTK2 (0.49) PTK2PTK2BTBK1SRCGSK3A
SCHEMBL669481 0.74 PTK2 (0.58) PTK2PTK2BTBK1SRCGSK3A
SCHEMBL669800 0.71 PTK2B (0.46) PTK2PTK2BTBK1SRCGSK3A
SCHEMBL15023735 0.71 PTK2B (0.46) PTK2PTK2BTBK1NEK2
SCHEMBL669843 0.71 PTK2B (0.49) PTK2PTK2BTBK1
SCHEMBL10125447 0.71 PTK2 (0.58) PTK2PTK2BTBK1SRCGSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2606034-B1 PYRIMIDINE DERIVATIVE AS FAK INHIBITORS MERCK PATENT GMBH (DE) 2016-03-09 EP disclosed
EP-2606034-A1 PYRIMIDINE DERIVATIVES AS FAK INHIBITORS Merck Patent GmbH (DE) 2013-06-26 EP disclosed
WO-2012022408-A1 PYRIMIDINE DERIVATIVES AS FAK INHIBITORS MERCK PATENT GMBH (DE) 2012-02-23 WO disclosed